October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
The Primer provides a general overview of immunology as it applies to cancer etiology, biology and therapy. The target audience for this program is basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows, and allied health professionals.
Topics Addressed
| • Adoptive T-Cell Therapy | • Immune Monitoring |
| • Cancer Vaccines | • Innate Immunity and Inflammation |
| • Cytokines | • Overview of Adaptive Immunity |
| • Dendritic Cells | • Regulatory Immune Cells |
| • Immune Modulating Antibodies | • Tumor Microenvironment |
|
Organizers |
|
|
Patrick Hwu, MD |
Walter J. Urba, MD, PhD |
Primer Educational Supporters
 |
 |
Click here to view all SITC program supporters.
